Hangzhou, China

Yongxin Robert Zhao

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Hangzhou Dac Biotech Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yongxin Robert Zhao. Retrieved from https://idiyas.com/inventor/yongxin-robert-zhao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0


Average Co-Inventor Count = 6.8

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Yongxin Robert Zhao in Biotechnology

Introduction

Yongxin Robert Zhao, an accomplished inventor from Hangzhou, China, is renowned for his contributions to the field of biotechnology. With two patents to his name, he has made significant strides in the development of conjugation linkers and related molecular technologies.

Latest Patents

His latest patents focus on "Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers." The inventions uniquely relate to linkers that comprise a group of propiolyl, substituted acryl (acryloyl), or disubstituted propanoyl. These linkers facilitate the conjugation of various compounds, particularly cytotoxic agents, to cell-binding molecules. This innovative approach has the potential to enhance therapeutic strategies in targeting specific cells in medical applications.

Career Highlights

Over the years, Yongxin has worked with several prominent companies, including Hangzhou Dac Biotech Co., Ltd. and Suzhou M-conji Biotech Co., Ltd. His experience in these organizations has helped him refine his skills and expertise within the biotech sector.

Collaborations

Throughout his career, Yongxin has collaborated with notable professionals in the field, including Qingliang Yang and Yuanyuan Huang. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

Yongxin Robert Zhao's inventiveness in developing conjugation linkers represents a significant advancement in biotechnology. His patents offer valuable insights and applications that can potentially revolutionize drug delivery systems, showcasing his role as a prominent figure in the ongoing evolution of this field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…